about
A current perspective on applications of macrocyclic-peptide-based high-affinity ligandsAutoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management.The novel S59P mutation in the TNFRSF1A gene identified in an adult onset TNF receptor associated periodic syndrome (TRAPS) constitutively activates NF-κB pathwayPurification of monoclonal antibodies from clarified cell culture fluid using Protein A capture continuous countercurrent tangential chromatography.Lowering serum lipids via PCSK9-targeting drugs: current advances and future perspectives.Alirocumab: PCSK9 inhibitor for LDL cholesterol reduction.
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Clinically useful monoclonal antibodies in treatment.
@ast
Clinically useful monoclonal antibodies in treatment.
@en
Clinically useful monoclonal antibodies in treatment.
@nl
type
label
Clinically useful monoclonal antibodies in treatment.
@ast
Clinically useful monoclonal antibodies in treatment.
@en
Clinically useful monoclonal antibodies in treatment.
@nl
prefLabel
Clinically useful monoclonal antibodies in treatment.
@ast
Clinically useful monoclonal antibodies in treatment.
@en
Clinically useful monoclonal antibodies in treatment.
@nl
P2860
P356
P1476
Clinically useful monoclonal antibodies in treatment.
@en
P2093
P2860
P356
10.1136/JCP.55.2.81
P407
P577
2002-02-01T00:00:00Z